We evaluated the histological features of the endometrium in relation to the bleeding pattern in a group of women receiving oral cyclical combined hormone replacement therapy (HRT), and compared the histological features with those of luteinizing hormone (LH)-dated endometrial biopsies obtained from healthy women at the time of sterilization. A total of 103 women completed 6 months of HRT therapy. All received a regimen of 2 mg oestradiol valerate daily, with 1 mg norethisterone added for the last 12 days of every 28-day cycle. Endometrial biopsies were scheduled for the end of the study (days 27-29 of the last cycle of therapy). Using the classical histological criteria, secretory endometrial changes were demonstrated in the majority (n ⍧ 89) of cases. The remaining were insufficient or inactive (n ⍧ 12), proliferative (n ⍧ 1) or atrophic (n ⍧ 1). Forty-nine women had a mean cycle length of less than 29 days (early bleeders), 50 women experienced cycles of more than 29 days (late bleeders) and four did not experience any bleeding. When the individual histological structures were examined, using image analysis, there were no statistically significant differences in the histological features when the long cycles in early bleeders were compared with those in late bleeders. LH-dated endometrium showed a high degree of homogeneity that was consistent with cycle day as described by the classic criteria, but HRT-treated endometrium exhibited a wide range of variability. HRT-treated endometrium from the subset of women who bled on or after day 29, and whose biopsies were obtained before the onset of bleeding, differed significantly from the endometrium taken at the corresponding phase of the physiological cycle. We conclude that the use of classical histological criteria, which are used in relation to the physiological cycle, in the study of HRT-treated endometria is inappropriate.
Introduction
During the menstrual cycle, the endometrium undergoes a series of well-defined histological changes programmed by the steroid hormones of the ovarian cycle. These histological changes are presumed to reflect sequential functional states of the endometrium, i.e. proliferation, a state 'receptive' to implantation during the mid luteal phase, and the changes programming the endometrium to a menstrual 'bleed' after regression of the corpus luteum and hormone withdrawal during the late luteal phase.
It is still not clear what histological features specifically reflect these states and this has impeded the assessment of the effects of exogenous steroid regimens on endometrial function. The focus of research in in-vitro fertilization (IVF) programmes has been to produce an optimally receptive endometrium by employing changes in the luteal phase which have been suggested to be associated with the receptive state, e.g. glandular and blood vessel maturation (Seif et al., 1992) . Although no morphological features have been unequivocally associated with implantation (Rizk et al., 1992 : Rogers et al., 1996 , there is evidence that functional protein expression may be more predictive of outcome (Rizk et al., 1992; Lessey et al., 1995) .
In contrast, the focus in hormone replacement therapy (HRT) research programmes has been directed towards preventing the histological appearance of features of hyperplasia, which has been traditionally perceived as the precursor of cancer. Endometrial hyperplasia has been linked with the use of unopposed oestrogen therapy (Whitehead et al., 1979) and, although originally a focus of controversy, it has become widely accepted that unopposed oestrogen replacement therapy is associated with a 3-25-fold increase in the risk of endometrial cancer (Ziel and Finkle, 1975; Smith et al., 1975; BarrettConnor, 1992) . To guard against these developments, the current practice is to add a minimum of 10 days (Whitehead et al., 1981) , but preferably 12-14 days, of progestogen to every 28-day treatment cycle (Woodruff and Pickar, 1994) . This, however, introduces a monthly 'hormone withdrawal' bleed which, especially if it becomes heavy, irregular or unpredictable, ranks among the most important causes for the discontinuation of therapy (Hahn et al., 1984; Nachtigall, 1990) and adversely affects the uptake of HRT (Al-Azzawi and Habiba, 1994) .
Little information is available concerning the response of the endometrium to exogenous sex steroid therapy, particularly in the post-menopausal state. However, in order to produce more effective exogenous steroidal treatment modalities, attempts have been made to correlate features of endometrial histology with the bleeding associated with HRT. In the normal menstrual cycle, histological changes occur in the endometrium during the late luteal phase, which may be associated with the onset of menstruation. Paradoxically, endometrial histological findings spanning the whole spectrum of atrophic, inactive, proliferative, early and late secretory, and hyperplastic endometrium have been reported in biopsies from the late progestogenic phase whilst on HRT from women exhibiting apparently 'normal' bleeding patterns (Padwick et al., 1986; Sturdee et al., 1994) . It may be that histological changes in the late luteal phase of normal menstrual cycle are not causally linked with bleeding, or that the mechanism(s) of bleeding associated with exogenous steroids, in the dose ranges employed in HRT, is different from that during the menstrual cycle.
In a previous study, we analysed the bleeding pattern in 103 women who received a 6-month treatment with a cyclical sequential combined HRT. We classified these women as 'early' or 'late' bleeders. The former were characterized by experiencing an increased frequency of 'short' cycles, i.e. cycle lengths of less than 29 days, an increased cycle length variability, a longer duration of bleeding, and a larger amount of blood loss compared with those of the latter group (Habiba et al., 1996) . Here, we report on the endometrial biopsies taken from these women during the late-progestogenic, i.e. 'pseudoluteal' phase, and we compare these with biopsies obtained during the luteal phase of the normal LH-dated cycle. Our aim was to determine whether features could be identified that may be more predictive of subsequent endometrial behaviour. If these were to be identified, they would be useful for monitoring women's responses to HRT, and might also have implications for the utility of the criteria traditionally used in endometrial assessment when applied to HRT-treated endometrium.
Materials and methods
Women on HRT were prescribed a regimen of 2 mg of oestradiol valerate daily with the addition of 1 mg of norethisterone from day 17 through to day 28 of each cycle (medication supplied by Solvay Pharma Hannover GmbH). Participants adhered to a rigid schedule with a pre-study assessment 2-3 weeks prior to commencement of the 168 days of active medication and with visits to clinic every 56 days. The inclusion and exclusion criteria and patient characteristics have been reported previously (Habiba et al., 1996) . An endometrial pipelle biopsy (Laboratoire CCD, Paris, France) was obtained prior to enrolment into the study. Patients were excluded if this biopsy could not be obtained because of administrative or technical reasons, or if the baseline biopsy showed evidence of endometrial hyperplasia or malignancy.
Patients filled in diary cards during the study period to document their intake of study medication and to record the days of bleeding and its severity. Day 1 of the cycle was taken as the beginning of the oestrogenic phase. Compliance was verified by checking the patients' diary cards and by collecting the returned empty medication packs. The documentation on the diaries was verified against the returned blister packs.
A total of 164 post-menopausal women was screened between December 1992 and September 1994. Subsequent to screening, 33 of them were found not to be eligible to continue and were withdrawn. Of 131 patients enrolled, 103 patients completed 6 months of treatment. The inclusion and exclusion criteria and the reasons for drop-out have been discussed previously (Habiba et al., 1996) . Another endometrial biopsy was planned for the final clinic visit that was scheduled for days 27 to 29 of the sixth cycle. The demographic 1675 characteristics of the study population and the bleeding pattern are detailed elsewhere (Habiba et al., 1996) . Patients were classified according to their cycle length characteristics into three groups: (i) early bleeders (n ϭ 49) who had a mean cycle length of less than 29 days (range 23.8-28.8, mean ϭ 27.0, SD ϭ 2.3); (ii) late bleeders (n ϭ 50) who had a mean cycle length of 29 or more days (range 29.0-33.2, mean ϭ 30.4, SD ϭ 1.3); and (iii) non-bleeders (n ϭ 4) who experienced no bleeding whilst on therapy.
The LH-dated natural cycle biopsies (n ϭ 30) were obtained by dilatation and curettage from healthy women with regular cycles at the time of scheduled tubal sterilization. They were all given a urine ovulation detection kit (Clearplan, Unipath, Bedford, UK) and instructed to its use. Sterilization and dilatation and curettage were performed in the early (day 2-6 after the LH peak), the mid (day 7-11 after the LH peak), or the late (day 12-14 after the LH peak) luteal phases, with the day of LH peak taken as day 0.
None of the women was using hormonal contraception or an intrauterine device, or had any pregnancies in the previous 6 months. Their mean age was 34.7 years (range 26-39 years), and mean parity was 3.2 (range 2-6). All women gave written consent to the procedure that was approved by the local ethics committee.
All endometrial samples were fixed in formalin and routinely processed and stained with haematoxylin and eosin. Endometrial sections were assessed according to the histological classification following standard criteria (Noyes et al., 1950; Demopoulos, 1982; Buckley and Fox, 1989) and by using image analysis.
Quantitative and semi-quantitative feature analysis
Biopsies were examined quantitatively or semi-quantitatively using image analysis in order to assess each histological feature seen in tissue sections. Five groups were compared: (i) late bleeders: the first 10 biopsies from the late bleeders' group from whom the biopsies were obtained between days 27-29 and before the onset of bleeding in the sixth treatment cycle; (ii) early bleeders: the 10 biopsies from the patients in the early bleeders' group from whom the biopsies were obtained between days 27-29 and from whom the biopsies were obtained before the onset of bleeding in the sixth treatment cycle; (iii) early luteal phase biopsies (n ϭ10); (iv) mid luteal phase biopsies (n ϭ10); and (v) late luteal phase biopsies (n ϭ10).
The image analysis system comprised an Axioplan (Carl-Zeiss) microscope connected to a video camera (Sony DXC-151P) and an Apple Macintosh computer with NIH image TM (version 1.51) software. Assessment was performed as follows: (i) Epithelial height was measured, and the percentage of the luminal and of the glandular epithelium lined by each type of epithelium (cuboidal, low columnar, columnar, and pseudostratified columnar) and the percentage showing apical or basal vacuoles were estimated in 17 random high-power fields (ϫ400). The mean for each section was calculated.
(ii) The glandular diameter of 17 randomly selected glands was measured employing high-power microscopy (ϫ200) and the measurements converted to metric scale using a measurement grid. (iii) The proportion of tubular and convoluted glands was calculated in a random selection of 20 glands per section. (iv) The glandular density was counted in 17 random high-power fields (ϫ400) per section.
(v) The proportion of glands (out of 20 glands) containing luminal secretions was counted, and the amount of secretion was graded using a semi-quantitative scale as: minimal ϭ 1; moderate ϭ 2; and abundant ϭ 3. The amount of secretion was multiplied by the proportion of glands that were positive to obtain a 'secretion score'. (vi) The percentage of glands containing glandular invaginations (telescoping) was counted in the whole section. (vii) The glandular apical margins were described as either smooth or irregular and the percentage exhibiting each feature was estimated in 20 glands using high-power (ϫ400) microscopy.
(viii) The stromal cellular density was calculated by counting the number of nuclei in 17 random high-power fields (ϫ1000) per section under oil immersion.
(ix) The presence or absence of decidualization, and whether this feature was present in the upper 1/3 of the stroma, was diffuse, or whether it was only present in a perivascular location was described. (x) The number of leukocytes per section was assessed semiquantitatively on a grading of: minimal/few ϭ 1; average ϭ 2; and heavy infiltrate ϭ 3.
Statistical analysis
As the standard deviation of the test parameters was unknown, the number of fields randomly selected from each section (n ϭ 17) was calculated in order to satisfy a one-sample t-test, with a power 1-b ϭ 0.90, and a two-sided α ϭ 0.01 to detect the population mean with a standardized difference d t ϭ 1 (Machin and Campbell, 1987) . The number of sections to be examined was calculated in order to satisfy a two-sided t-test with a power 1-b ϭ 0.90 and a two-sided α ϭ 0.05 to detect a 20% difference between the means. A pilot calculation gave the estimated d t ϭ 1. The results were analysed using the two-sided unpaired t-test, and the Mann-Whitney test.
Results

Standard histological assessment
The histological classification of the pre-enrolment biopsies is shown in Table I . The end biopsy material was insufficient for assessment in only eight cases (two of these included endocervical epithelium), and no cases exhibited hyperplastic or neoplastic changes. The only proliferative sample was the biopsy obtained on day 13 of the cycle. In 89 (86.4%) of patients who completed the study, a secretory histology was recorded. Those patients who had biopsies taken on days 27-29 included the only four patients who did not experience bleeding during the study, and it was only from these patients that endometrial biopsies classified as inactive were obtained at the end of the study (Table I ). Thus 100% of the patients from whom biopsies were taken on days 27-29 (n ϭ 85), and 1676 who exhibited bleeding during the study period (n ϭ 81), and in whom sufficient endometrial tissue was obtained (n ϭ 75) had secretory endometrium on histology.
The relation between the timing of the biopsy and the onset of bleeding in the index cycle in the early (n ϭ 49), the late (n ϭ 50), and the non-bleeder (n ϭ 4) groups is shown in Table II . Out of the 85 biopsies which were taken on days 27-29, 75 exhibited secretory endometrium and, of these, 33 were early bleeders and 42 were late bleeders. The pre-study biopsies of these 75 women exhibited atrophic endometrium in 41 cases, inactive endometrium in 15 cases and proliferative endometrium in three cases and was insufficient in 16 cases. Thus, in all these patients, the secretory endometrial histology was induced in response to HRT. The pre-study endometrium in the four patients who did not experience withdrawal bleeding exhibited atrophic endometrium in one case and inactive endometrium in three cases.
Qualitative histological assessment
Although the majority of biopsy specimens were classified as 'secretory endometrium' using the standard histological criteria, the endometrial sections from HRT-treated women, which were classified as such, were characterized by wide variability as regards the presence of 'secretory' features throughout the sections. This was in contrast to the more uniform features exhibited by sections of secretory endometrial specimens obtained from the early, mid, and late luteal phase of the physiological cycle (Figure 1) .
The glands featured variable development: some were well developed, i.e. tubular or convoluted, but others were of a narrow and variable calibre. The epithelial lining exhibited a variety of secretory changes, which ranged from glands with abundant supra-nuclear vacuolation to exhausted secretory changes, although these characteristics were poorly developed in the majority of cases. Most glands were lined with inactive or cubocolumnar epithelium. Few glands exhibited subnuclear vacuolation. Apoptotic bodies were sometimes seen. Glandular telescoping was noted in a large proportion (40%) of sections. In some cases glands appeared to be surrounded by an intense leukocytic infiltrate (Figure 2 ). The stroma featured small round or spindle cells and, although sometimes the stroma exhibited well-developed decidualization, this was often variable and sometimes absent. Stromal oedema or breakdown was apparent in some of the specimens. Vasculature was of narrow calibre sometimes with thin muscular walls, but on occasions this was well developed. Dilated capillaries were often noted. Area-to-area dysynchrony as well as gland-to-stroma dysynchrony was seen to some extent in all sections examined. The presence of leukocytes in some sections was extensive but in others was difficult to distinguish.
Quantitative and semi-quantitative histological assessment
The results of the quantitative and semi-quantitative analysis are shown in Tables III and IV. Comparing the late pseudoluteal phase endometrium of HRT-treated cycles between the early and the late bleeders showed no significant differences (Table III) .
Since late bleeders from whom biopsies were obtained before the onset of bleeding in the biopsy cycle and whose biopsies exhibited 'secretory endometrium' represent the equivalent of the late luteal phase endometrium of the natural cycle, comparison was made between these two groups. The features seen in the endometrial epithelium, the glands and the stroma exhibited some significant differences. The luminal epithelium contained more cuboidal and pseudostratified cells and less low columnar and columnar cells. Glandular epithelial cells were also predominantly shorter, but contained more apical vacuoles. The glands were less numerous but of similar diameter, and the total glandular area was smaller in HRT-treated endometrium. The glands were also more tubular, less convoluted, and contained less luminal secretion, and the apical margins of the glandular cells were smoother than those found in the natural cycle. The stroma was less cellular than in the natural cycle, but there was no statistically significant difference in the degree of stromal oedema, haemorrhage or decidualization. Leukocyte infiltrate was significantly higher in HRT-treated endometrium.
Comparison between the late bleeders in the pseudoluteal phase of HRT and the early, mid and late luteal phases of the normal cycle, demonstrated that the HRT-treated endometrium shared some features with the early luteal phase (e.g. the characteristics of the apical margins of the glandular epithelial cells, the incidence of pseudostratification in the luminal epithelium and of low columnar cells in the glandular epithelium, and the gland number). Some features were shared with the mid luteal phase (e.g. the incidence of apical vacuoles in the glandular and luminal epithelium) and some features were similar to the late luteal phase (e.g. gland diameters). On the other hand, the high incidence of cuboidal cells, and the low incidence of low columnar and columnar cells were unique to HRT-treated endometrium. The stroma under the influence of HRT contained some of the features of the mid luteal phase, but mostly exhibited features of the late luteal phases of the natural cycles.
Discussion
All adequate biopsies obtained between days 27-29, from women experiencing regular cycles, were secretory as assessed by the standard histological criteria and, in all cases where diagnosable biopsies were obtained, the endometrium exhibited a histological response to HRT, except in those four patients who did not bleed. These four patients' endometrial biopsies were inactive. Interestingly, these patients were heavy smokers and a lack of a histological response might be related to the hypo-oestrogenic state in heavy smokers (Habiba et al., 1996) . Our data, thus, do not support the previously published studies 1678 that indicated that a significant proportion of biopsies taken in the pseudoluteal phase of the HRT cycle from patients having regular cycles exhibit proliferative or atrophic histology, e.g. 13% in the study by Sturdee et al. (1994) and 16% in the study by Padwick et al. (1986) . In addition, in these studies, 27% and 13% of patients, respectively, could not be assessed because of scant or absent biopsy material, which was considered to indicate the presence of atrophic or inactive endometrium. The apparent lack of an endometrial response to HRT in women with regular cycles, cited in the previously published work, would be difficult to explain if the biopsies were adequate and optimally timed. The presence of endocervical epithelium in two of our patients whose biopsies were insufficient for adequate histological assessment suggests that the 1679 lack of response was because the biopsies were obtained from the less responsive isthmus.
Endometrial biopsies obtained on days 11-13 of the pseudoluteal phase (cycle days 27-29) were classified according to standard histological assessment as secretory, irrespective of whether the biopsies were obtained from 'early' or 'late' bleeders. This supports a lack of correlation between classically defined histological features and the time of bleeding in variation of end-organ response. This difference may thus be due to extrauterine factors in these patients, e.g. steroid uptake and metabolism, which may also exhibit temporal variation. Since cycle variability is reflected clinically in unpredictable bleeding, which is associated with discontinuance of HRT and in low compliance, identifying these factors will have significant clinical implications.
In contrast to the physiological cycle endometrium, HRTtreated endometria from the pseudoluteal phase exhibited a high degree of heterogeneity, which may represent a poor control of endometrial proliferation and differentiation with the intake of exogenous steroid hormones. The total number of leukocytes is increased in the HRT-treated endometrium, but whether this represents an increase in the characteristic CD56-enriched population of the late luteal phase endometrium, or represents a different subpopulation, awaits further investigation.
The histological features of HRT-treated endometrium differed significantly from those noted in any stage of the luteal phase of the menstrual cycle. The glandular component exhibited a mixture of features, some of which were similar to those seen in the early, the mid or in the late luteal phase, as well as unique features that are not normally noted in the luteal phase, whilst the stroma exhibited mostly advanced features. This supports the qualitative impression of glandular to stromal dysynchrony in HRT-treated endometrium. This suggests that there may be a disproportion between the doses and/or the effect of the oestrogen and the progestogen in this regimen (Good and Moyer, 1968) . Comparing the histology of the group who experienced regular withdrawal bleeding whilst on HRT to the endometrium of the late luteal phase of the physiological cycle, demonstrated that the main similarities between the two groups was in the histological features of the stroma. This suggests that one or more of the stromal features 1681 may be the important determinant of bleeding. It is interesting that the endometrial samples obtained after the onset of bleeding on HRT exhibited secretory features. This may be explained by patchy endometrial maturation/shedding, which may, in turn, be related to the fact that hormone administration in this regimen was continued to complete the 12 days of combined oestrogen and progestogen, irrespective of the onset of bleeding, and that the vast majority of these biopsies were obtained within 1-2 days after the onset of bleeding. The reduced glandular area reported in the present study is similar to that reported in IVF cycles (Rogers et al., 1996) . Reduced glandular area has been reported with clomiphene citrate treatment, but was not found in high oestrogen regimens, which supports a central role for oestrogen in glandular development (Rogers et al., 1996) . This supports our hypothesis that the regimen we employed is relatively hypo-oestrogenic.
Some of the observed histological discrepancies may be related to the use of the synthetic progestogen norethisterone. Norethisterone is widely used in HRT preparations but has mild androgenic effects, which may be mediated through the androgen receptors that are present in the endometrial epithelium as well as in the stroma (Mertens et al., 1996) . It is also possible that some of the histological discrepancies that we observed in HRT endometrium may be due to the fact that, with the use of HRT, the endometrium is exposed to 12 days of continuous progestogen rather than the fluctuations that occur in the physiological cycle.
This study has demonstrated the dissociation between the classical histological features in the endometrium and the occurrence of bleeding. This dissociation between morphology and function has far-reaching implications, as it raises important questions concerning the utility of traditional histological classification in the assessment of the different states of the endometrium under HRT. This conclusion is supported by the previously described discrepancy between endometrial histological features and immunohistochemical markers (Bell, 1990; Rizk et al., 1992) Our study also indicates that future research should be focused on parameters known to be related to function, and should aim to discover new parameters. Only if such relationships are known and measured, can we adequately monitor current preparations, and design new HRT preparations for use in clinical practice.
